Exelixis
EXEL
#1850
Rank
C$15.03 B
Marketcap
C$56.08
Share price
-2.55%
Change (1 day)
-0.35%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of December 2025 : C$3.86 Billion

According to Exelixis's latest financial reports the company's total assets are C$3.86 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31C$3.89 B-7.91%
2024-12-31C$4.22 B8.39%
2023-12-31C$3.90 B-6.36%
2022-12-31C$4.16 B25%
2021-12-31C$3.33 B22.35%
2020-12-31C$2.72 B10.66%
2019-12-31C$2.46 B27.12%
2018-12-31C$1.93 B135.16%
2017-12-31C$0.82 B2.91%
2016-12-31C$0.80 B73.65%
2015-12-31C$0.46 B22.89%
2014-12-31C$0.37 B-29.98%
2013-12-31C$0.53 B-25.29%
2012-12-31C$0.71 B79.25%
2011-12-31C$0.40 B10.92%
2010-12-31C$0.36 B-0.19%
2009-12-31C$0.36 B-26.01%
2008-12-31C$0.48 B18.78%
2007-12-31C$0.41 B-10.7%
2006-12-31C$0.46 B18.85%
2005-12-31C$0.38 B10.7%
2004-12-31C$0.34 B-24.61%
2003-12-31C$0.46 B-13.34%
2002-12-31C$0.53 B-3%
2001-12-31C$0.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$270.54 B 6,903.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$283.47 B 7,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$122.41 B 3,069.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$206.86 B 5,255.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$175.93 B 4,454.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$122.27 B 3,065.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$111.98 B 2,799.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
C$37.53 M-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.13 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA